文献速递母胎医学

12个埃及家系丝氨酸生物合成缺陷的胎儿表型分析与全外显子组测序:新临床与等位基因发现及奠基者效应

Fetal Phenotyping and Whole Exome Sequencing for 12 Egyptian Families With Serine Biosynthesis Defect: Novel Clinical and Allelic Findings With a Founder Effect.
PubMed 文献 · Prenat Diagn · 2024-12-05

该研究对12个无亲缘关系的埃及家系中疑似Neu-Laxova综合征(NLS)的胎儿进行详细胎儿超声、出生后评估及全外显子组测序(WES),并合并文献中所有分子确诊NLS病例进行综述。结果发现宫内惊厥、半椎体、诞生牙、前脑无裂畸形、菱脑融合等新临床表现,鉴定PSAT1和PHGDH基因的7个和2个可能致病变异,其中4个为新变异,PSAT1 c.734G>A missense变异被提出为埃及人奠基者变异。结论认为该队列扩展了丝氨酸生物合成障碍谱,并阐明产前外显子组测序在致死性疾病中的作用。

要点

  • 在12个埃及家系疑似NLS胎儿中,WES鉴定PSAT1基因7个、PHGDH基因2个可能致病变异。
  • 发现宫内惊厥、半椎体、诞生牙、前脑无裂畸形、菱脑融合等新临床表现。
  • PSAT1 c.734G>A missense变异被提出为埃及人群奠基者变异。

核心结论

  • 该队列扩展了丝氨酸生物合成障碍的临床与等位基因谱,并提示产前外显子组测序在致死性疾病中的价值。

研究设计与样本

  • 对12个无亲缘关系的埃及家系中疑似NLS的12个胎儿进行详细胎儿超声检查、出生后评估及全外显子组测序(WES),并合并文献中所有分子确诊NLS病例进行综述。

主要发现

  • 观察到宫内惊厥、半椎体、诞生牙、前脑无裂畸形和菱脑融合等新临床表现。
  • 分子分析鉴定PSAT1基因7个和PHGDH基因2个可能致病变异,其中4个为新变异。
  • PSAT1 c.734G>A missense变异被提出为埃及人奠基者变异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to improve our understanding of severe serine biosynthesis defects through a comprehensive description of prenatal, and postnatal manifestations and the mutational spectrum in a new cohort of 12 unrelated Egyptian Families. METHODS: Detailed fetal ultrasound examination, postnatal assessment, and whole exome sequencing (WES) were performed in a cohort of 12 fetuses with suspected Neu-Laxova syndrome (NLS), the most severe expression of serine biosynthesis defects. Additionally, a comprehensive review of the literature was conducted by merging the data from all the molecularly-confirmed cases with ours to gain a better understanding of the clinical variability of NLS. RESULTS: Novel clinical manifestations including intrauterine convulsions, hemivertebrae, natal teeth, holoprosencephaly, and rhombencephalosynapsis were observed. Molecular analysis identified 7 and 2 likely disease-causing variants in the PSAT1 and PHGDH genes, respectively. Four of them were novel, including the c.734G>A missense variant in PSAT1, which has been proposed to be a founder variant among Egyptians. CONCLUSION: The present cohort expands the spectrum of serine biosynthesis disorders. Moreover, it illuminates the role of prenatal exome sequencing in lethal conditions constituting the most severe end of already-known human diseases.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. El-Dessouky SH, Sharaf-Eldin WE, Aboulghar MM, et al. Fetal Phenotyping and Whole Exome Sequencing for 12 Egyptian Families With Serine Biosynthesis Defect: Novel Clinical and Allelic Findings With a Founder Effect. Prenat Diagn. 2024. PMID: 39638571. doi:10.1002/pd.6697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。